115 related articles for article (PubMed ID: 35882522)
1. Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes.
Antúnez-Lay A; Podlipnik S; Carrera C; Potrony M; Tell-Martí G; Badenas C; Puig-Butille JA; Espinosa N; Puig S; Malvehy J
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2364-2372. PubMed ID: 35882522
[TBL] [Abstract][Full Text] [Related]
2. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
[TBL] [Abstract][Full Text] [Related]
3. Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.
Fargnoli MC; Sera F; Suppa M; Piccolo D; Landi MT; Chiarugi A; Pellegrini C; Seidenari S; Peris K
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1768-75. PubMed ID: 24588892
[TBL] [Abstract][Full Text] [Related]
4. Role of the CDKN2A locus in patients with multiple primary melanomas.
Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
Dalmasso B; Pastorino L; Ciccarese G; Andreotti V; Grillo F; Mastracci L; Spagnolo F; Ballestrero A; Queirolo P; Bruno W; Ghiorzo P
J Am Acad Dermatol; 2019 May; 80(5):1263-1271. PubMed ID: 30274933
[TBL] [Abstract][Full Text] [Related]
7. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
8. Survival and tumor characteristics of patients presenting with single primary versus second primary melanoma lesions.
Sarver MM; Rames JD; Beasley GM; Gao J; Jung SH; Chen SC
J Am Acad Dermatol; 2023 May; 88(5):1033-1039. PubMed ID: 35525504
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A mutations in multiple primary melanomas.
Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
[TBL] [Abstract][Full Text] [Related]
11. Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants.
Li C; Liu T; Tavtigian SV; Boucher K; Kohlmann W; Cannon-Albright L; Grossman D
Melanoma Res; 2020 Jun; 30(3):247-251. PubMed ID: 31567591
[TBL] [Abstract][Full Text] [Related]
12. Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.
Eskandarpour M; Hashemi J; Kanter L; Ringborg U; Platz A; Hansson J
J Natl Cancer Inst; 2003 Jun; 95(11):790-8. PubMed ID: 12783933
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors of Subsequent Primary Melanomas in Austria.
Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
[TBL] [Abstract][Full Text] [Related]
14. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
16. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
[TBL] [Abstract][Full Text] [Related]
17. Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas.
Grazziotin TC; Alarcon I; Bonamigo RR; Carrera C; Potrony M; Aguilera P; Puig-Butillé JA; Brito J; Badenas C; Alós L; Malvehy J; Puig S
JAMA Dermatol; 2016 Oct; 152(10):1099-1105. PubMed ID: 27579522
[TBL] [Abstract][Full Text] [Related]
18. Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study.
Savoia P; Osella-Abate S; Deboli T; Marenco F; Stroppiana E; Novelli M; Fierro MT; Bernengo MG
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):882-8. PubMed ID: 21819449
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG
Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867
[TBL] [Abstract][Full Text] [Related]
20. Multiple primary melanomas: A literature review.
Apostu AP; Ungureanu L; Halmagyi SR; Trufin II; Șenilă SC
Medicine (Baltimore); 2023 Jul; 102(30):e34378. PubMed ID: 37505174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
